WASHINGTON, DC (GenomeWeb News) - A year after an $8.1 billion agreement to sell two of its diagnostic divisions to General Electric fell apart, Abbott Laboratories has no intentions of getting rid of those divisions or any other parts of its diagnostics business, company officials said Tuesday at the annual meeting of the American Association for Clinical Chemistry.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.